Vaccine Effectiveness Against Medically Attended, Laboratory-Confirmed Influenza Among Children Aged 6 to 59 Months, 2003–2004
- 1 March 2007
- journal article
- research article
- Published by American Academy of Pediatrics (AAP)
- Vol. 119 (3) , e587-e595
- https://doi.org/10.1542/peds.2006-1878
Abstract
OBJECTIVES. Influenza is a leading cause of illness among children. Studies rarely have measured influenza vaccine effectiveness among young children, particularly when antigenic match between vaccine and circulating viruses is suboptimal. We assessed vaccine effectiveness against medically attended, laboratory-confirmed influenza for children who were aged 6 to 59 months during the 2003–2004 influenza season. METHODS. In a case-control study that was conducted in a single pediatric practice, case patients who were aged 6 to 59 months and had laboratory-confirmed influenza were age matched 1:2 to eligible control subjects. Vaccination status was ascertained as of the date of the case patient’s symptom onset. Conditional logistic regression was used to calculate vaccine effectiveness, adjusting for underlying medical conditions and health care usage. RESULTS. We identified 290 influenza case patients who were seen for medical care from November 1, 2003, to January 31, 2004. Vaccine effectiveness among fully vaccinated children, compared with unvaccinated children, was 49%. Partially vaccinated children who were aged 6 to 23 months had no significant reduction in influenza (vaccine effectiveness: −70%), but partially vaccinated children who were aged 24 to 59 months had a significant (65%) reduction in influenza, compared with unvaccinated children. CONCLUSIONS. Full vaccination provided measurable protection against laboratory-confirmed influenza among children who were aged 6 to 59 months during a season with suboptimal vaccine match. No vaccine effectiveness was identified with partial vaccination among children who were aged 6 to 23 months, affirming that children need to be fully vaccinated to obtain protective effects. These results strengthen the evidence of the vaccine’s ability to reduce substantially the burden of disease in this age group.Keywords
This publication has 25 references indexed in Scilit:
- Immunogenicity and Reactogenicity of 1 versus 2 Doses of Trivalent Inactivated Influenza Vaccine in Vaccine‐Naive 5–8‐Year‐Old ChildrenThe Journal of Infectious Diseases, 2006
- Benefits of influenza vaccine in US elderly--appreciating issues of confounding bias and precision.International Journal of Epidemiology, 2006
- Effectiveness of the 2003–2004 Influenza Vaccine Among Children 6 Months to 8 Years of Age, With 1 vs 2 DosesPediatrics, 2005
- Poor immune responses to influenza vaccination in infantsVaccine, 2004
- Reduction of the Influenza Burden in ChildrenPediatrics, 2002
- Confounding by indication in non-experimental evaluation of vaccine effectiveness: the example of prevention of influenza complicationsJournal of Epidemiology and Community Health, 2002
- Burden of Interpandemic Influenza in Children Younger than 5 Years: A 25‐Year Prospective StudyThe Journal of Infectious Diseases, 2002
- Safety and immunogenicity of a paediatric presentation of an influenza vaccineArchives of Disease in Childhood, 2000
- Studies of the 1996–1997 Inactivated Influenza Vaccine among Children Attending Day Care: Immunologic Response, Protection against Infection, and Clinical EffectivenessThe Journal of Infectious Diseases, 2000
- The Effect of Influenza on Hospitalizations, Outpatient Visits, and Courses of Antibiotics in ChildrenNew England Journal of Medicine, 2000